Publication | Closed Access

Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia

Electrophysiologic ProfileCardiogenic ShockElectrophysiological EvaluationCardiovascular DiseaseMedicineIntravenous DofetilideCardiac ElectrophysiologyElectrophysiologyPharmacotherapyPublic HealthPharmacologyCardiologyEmergency MedicineAnesthesiologyCardiac Arrest